NovoCure NVCR Asset write-downs
Asset write-downs at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's asset write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's asset write-downs?
- NovoCure (NVCR) reported asset write-downs of $712K in Q1 2026.
- How has NovoCure's asset write-downs changed year-over-year?
- NovoCure's asset write-downs decreased by 68.5% year-over-year, from $2.26M to $712K.
- What is the long-term trend for NovoCure's asset write-downs?
- Over 4 years (2021 to 2025), NovoCure's asset write-downs has grown at a 65.3% compound annual growth rate (CAGR), from $649K to $4.85M.